Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Does small volume metastatic lymph node disease affect long-term prognosis in early cervical cancer?

Nica A, Gien LT, Ferguson SE, Covens A.

Int J Gynecol Cancer. 2019 Dec 22. pii: ijgc-2019-000928. doi: 10.1136/ijgc-2019-000928. [Epub ahead of print]

PMID:
31871114
2.

Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer.

Lee YC, Jivraj N, Wang L, Chawla T, Lau J, Croke J, Allard JP, Stuart-McEwan T, Nathwani K, Bowering V, Karakasis K, O'Brien C, Shlomovitz E, Ferguson SE, Buchanan S, Ng P, Cyriac S, Tinker L, Dhani N, Oza AM, Lheureux S.

J Oncol Pract. 2019 Dec;15(12):e1066-e1075. doi: 10.1200/JOP.18.00793. Epub 2019 Sep 24.

PMID:
31550202
3.

Reply.

Cusimano MC, Ferguson SE.

Am J Obstet Gynecol. 2020 Jan;222(1):96-97. doi: 10.1016/j.ajog.2019.09.017. Epub 2019 Sep 19. No abstract available.

PMID:
31542251
4.

Clinical Outcomes of Surgically Unresectable Endometrial Cancers.

Conway JL, Lukovic J, Ferguson SE, Zhang J, Xu W, Dhani N, Croke J, Fyles A, Milosevic M, Rink A, Rouzbahman M, Han K.

Am J Clin Oncol. 2019 Oct;42(10):777-782. doi: 10.1097/COC.0000000000000600.

PMID:
31503063
5.

Dyadic coping mediates the effects of attachment on quality of life among couples facing ovarian cancer.

Crangle CJ, Torbit LA, Ferguson SE, Hart TL.

J Behav Med. 2019 Aug 29. doi: 10.1007/s10865-019-00096-3. [Epub ahead of print]

PMID:
31468293
6.

Patient-physician relationships, health self-efficacy, and gynecologic cancer screening among women with Lynch syndrome.

McGarragle KM, Aronson M, Semotiuk K, Holter S, Hare CJ, Ferguson SE, Cohen Z, Hart TL.

Hered Cancer Clin Pract. 2019 Aug 13;17:24. doi: 10.1186/s13053-019-0123-7. eCollection 2019.

7.

Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer.

Cusimano MC, Baxter NN, Gien LT, Moineddin R, Liu N, Dossa F, Willows K, Ferguson SE.

Am J Obstet Gynecol. 2019 Dec;221(6):619.e1-619.e24. doi: 10.1016/j.ajog.2019.07.009. Epub 2019 Jul 6.

8.

Patterns of recurrence and impact on survival in patients with clear cell ovarian carcinoma.

Hogen L, Vicus D, Ferguson SE, Gien LT, Nofech-Mozes S, Lennox GK, Bernardini MQ.

Int J Gynecol Cancer. 2019 Sep;29(7):1164-1169. doi: 10.1136/ijgc-2019-000287. Epub 2019 Jul 3.

PMID:
31273067
9.

Barriers to care for women with low-grade endometrial cancer and morbid obesity: a qualitative study.

Cusimano MC, Simpson AN, Han A, Hayeems R, Bernardini MQ, Robertson D, Kives SL, Satkunaratnam A, Baxter NN, Ferguson SE.

BMJ Open. 2019 Jun 27;9(6):e026872. doi: 10.1136/bmjopen-2018-026872.

10.

FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.

Plante M, van Trommel N, Lheureux S, Oza AM, Wang L, Sikorska K, Ferguson SE, Han K, Amant F.

Int J Gynecol Cancer. 2019 Jun;29(5):969-975. doi: 10.1136/ijgc-2019-000398. Epub 2019 May 17.

PMID:
31101688
11.

Laparoscopic and robotic hysterectomy in endometrial cancer patients with obesity: a systematic review and meta-analysis of conversions and complications.

Cusimano MC, Simpson AN, Dossa F, Liani V, Kaur Y, Acuna SA, Robertson D, Satkunaratnam A, Bernardini MQ, Ferguson SE, Baxter NN.

Am J Obstet Gynecol. 2019 Nov;221(5):410-428.e19. doi: 10.1016/j.ajog.2019.05.004. Epub 2019 May 10. Review.

PMID:
31082383
12.

Impact of a novel prioritization framework on clinician-led oncology drug submissions.

Keech J, Beca J, Eisen A, Kennedy E, Kim J, Kouroukis CT, Darling G, Ferguson SE, Finelli A, Petrella TM, Perry JR, Chan K, Gavura S.

Curr Oncol. 2019 Apr;26(2):e155-e161. doi: 10.3747/co.26.4501. Epub 2019 Apr 1.

13.

Interobserver Agreement for Mismatch Repair Protein Immunohistochemistry in Endometrial and Nonserous, Nonmucinous Ovarian Carcinomas.

Sari A, Pollett A, Eiriksson LR, Lumsden-Johanson B, Van de Laar E, Kazerouni H, Salehi A, Sur M, Lytwyn A, Ferguson SE.

Am J Surg Pathol. 2019 May;43(5):591-600. doi: 10.1097/PAS.0000000000001220.

PMID:
30864976
14.

Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective.

Lee YC, Jivraj N, O'Brien C, Chawla T, Shlomovitz E, Buchanan S, Lau J, Croke J, Allard JP, Dhar P, Laframboise S, Ferguson SE, Dhani N, Butler M, Ng P, Stuart-McEwan T, Savage P, Tinker L, Oza AM, Lheureux S.

Obstet Gynecol Int. 2018 May 17;2018:1867238. doi: 10.1155/2018/1867238. eCollection 2018. Review.

15.

Brachy-ing Unresectable Endometrial Cancers with Magnetic Resonance Guidance.

Conway JL, Lukovic J, Laframboise S, Ferguson SE, Han K.

Cureus. 2018 Mar 5;10(3):e2274. doi: 10.7759/cureus.2274.

16.

Prospective cohort study comparing quality of life and sexual health outcomes between women undergoing robotic, laparoscopic and open surgery for endometrial cancer.

Ferguson SE, Panzarella T, Lau S, Gien LT, Samouëlian V, Giede C, Steed H, Le T, Renkosinski B, Bernardini MQ.

Gynecol Oncol. 2018 Jun;149(3):476-483. doi: 10.1016/j.ygyno.2018.04.558. Epub 2018 Apr 19.

17.

Empowering patients and caregivers with knowledge: The development of a nurse-led gynecologic oncology chemotherapy education class.

Jivraj N, Gallagher LO, Papadakos J, Abdelmutti N, Trang A, Ferguson SE.

Can Oncol Nurs J. 2018 Feb 1;28(1):4-7. doi: 10.5737/2368807628147. eCollection 2018 Winter.

18.

Autonomiser les patients et les soignants grâce au savoir : Élaboration d’une formation sur la chimiothérapie en gynécologie oncologique dirigée par le personnel infirmier.

Jivraj N, Gallagher LO, Papadakos J, Abdelmutti N, Trang A, Ferguson SE.

Can Oncol Nurs J. 2018 Feb 1;28(1):8-12. doi: 10.5737/23688076281812. eCollection 2018 Winter. French. No abstract available.

PMID:
31148637
Free PMC Article
19.

The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancer.

May T, Stewart JM, Bernardini MQ, Ferguson SE, Laframboise S, Jiang H, Rosen B.

Int J Gynaecol Obstet. 2018 Feb;140(2):247-252. doi: 10.1002/ijgo.12376. Epub 2017 Nov 26.

PMID:
29095487
20.

Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?

Hogen L, Brar H, Covens A, Bassiouny D, Bernardini MQ, Gien LT, Ferguson SE, Vicus D.

Gynecol Oncol. 2017 Oct;147(1):54-60. doi: 10.1016/j.ygyno.2017.07.128. Epub 2017 Jul 29.

PMID:
28760368
21.

Implementing a Cervical Sentinel Lymph Node Biopsy Program: Quality Improvement in Gynaecologic Oncology.

Cusimano MC, Walker R, Bernardini MQ, Bouchard-Fortier G, Laframboise S, May T, Murphy J, Rosen B, Covens A, Clarke B, Shaw P, Rouzbahman M, Mohan R, Ferguson SE.

J Obstet Gynaecol Can. 2017 Aug;39(8):659-667. doi: 10.1016/j.jogc.2017.02.017.

PMID:
28729099
22.

Comparison of three surgical approaches for staging lymphadenectomy in high-risk endometrial cancer.

Pulman KJ, Dason ES, Philp L, Bernardini MQ, Ferguson SE, Laframboise S, Atenafu EG, May T.

Int J Gynaecol Obstet. 2017 Mar;136(3):315-319. doi: 10.1002/ijgo.12073. Epub 2017 Jan 12.

PMID:
28078775
23.

Uterine Clear Cell Carcinoma: Does Adjuvant Chemotherapy Improve Outcomes?

Nguyen JM, Bouchard-Fortier G, Bernardini MQ, Atenafu EG, Han G, Vicus D, Ferguson SE, Gien LT.

Int J Gynecol Cancer. 2017 Jan;27(1):69-76. doi: 10.1097/IGC.0000000000000839.

PMID:
27668398
24.

Intraoperative lymph node evaluation using 18F-FDG and a hand-held gamma probe in endometrial cancer surgery--a pilot study.

Metser U, McVey R, Ferguson SE, Halankar J, Bernardini MQ.

Eur J Gynaecol Oncol. 2016;37(3):362-6.

PMID:
27352565
25.

How Common Is the Growing Teratoma Syndrome in Patients With Ovarian Immature Teratoma?

Van Nguyen JM, Bouchard-Fortier G, Ferguson SE, Covens A.

Int J Gynecol Cancer. 2016 Sep;26(7):1201-6. doi: 10.1097/IGC.0000000000000751.

PMID:
27258729
26.

Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study.

Köbel M, Atenafu EG, Rambau PF, Ferguson SE, Nelson GS, Ho TC, Panzarella T, McAlpine JN, Gilks CB, Clarke BA, Bernardini MQ.

Gynecol Oncol. 2016 Jun;141(3):559-563. doi: 10.1016/j.ygyno.2016.04.008. Epub 2016 Apr 16.

PMID:
27072807
27.

Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC).

Bernardini MQ, Gien LT, Lau S, Altman AD, Gilks B, Ferguson SE, Köbel M, Samouëlian V, Wesa M, Cameron A, Nelson G, Han G, Clarke B, Ho TC, Panzarella T, Atenafu EG, McAlpine JN.

Gynecol Oncol. 2016 Apr;141(1):148-54. doi: 10.1016/j.ygyno.2016.02.002. Epub 2016 Feb 5.

PMID:
26854651
28.

A comparison of the toxicity and tolerability of two intraperitoneal chemotherapy regimens for advanced-stage epithelial ovarian cancer.

Bouchard-Fortier G, Rosen B, Vyarvelska I, Pasetka M, Covens A, Gien LT, Kupets R, Pulman K, Ferguson SE, Vicus D.

Gynecol Oncol. 2016 Jan;140(1):36-41. doi: 10.1016/j.ygyno.2015.11.005. Epub 2015 Nov 4.

PMID:
26546964
29.

Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers.

Altman AD, Ferguson SE, Atenafu EG, Köbel M, McAlpine JN, Panzarella T, Lau S, Gien LT, Gilks B, Clarke B, Cameron A, Nelson G, Han G, Samouëlian V, Ho TC, Louie K, Bernardini MQ.

Gynecol Oncol. 2015 Nov;139(2):268-74. doi: 10.1016/j.ygyno.2015.09.001. Epub 2015 Sep 6.

PMID:
26352641
30.

Sex: Taboos, Assumptions, and Evidence.

Bezjak A, Ferguson SE.

J Clin Oncol. 2015 Oct 20;33(30):3370-1. doi: 10.1200/JCO.2015.62.9899. Epub 2015 Sep 8. No abstract available.

PMID:
26351342
31.

Effectiveness of the risk of malignancy index and the risk of ovarian malignancy algorithm in a cohort of women with ovarian cancer: does histotype and stage matter?

Lennox GK, Eiriksson LR, Reade CJ, Leung F, Mojtahedi G, Atenafu EG, Ferguson SE, Murphy J, Diamandis EP, Kulasingam V, Bernardini MQ.

Int J Gynecol Cancer. 2015 Jun;25(5):809-14. doi: 10.1097/IGC.0000000000000442.

PMID:
25855958
32.

Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer.

Eiriksson L, Aronson M, Clarke B, Mojtahedi G, Massey C, Oza AM, Gallinger S, Pollett A, Mackay H, Bernardini MQ, Ferguson SE.

Gynecol Oncol. 2015 Feb;136(2):311-6. doi: 10.1016/j.ygyno.2014.12.023. Epub 2014 Dec 19.

PMID:
25529831
33.

Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.

Ferguson SE, Aronson M, Pollett A, Eiriksson LR, Oza AM, Gallinger S, Lerner-Ellis J, Alvandi Z, Bernardini MQ, MacKay HJ, Mojtahedi G, Tone AA, Massey C, Clarke BA.

Cancer. 2014 Dec 15;120(24):3932-9. doi: 10.1002/cncr.28933. Epub 2014 Jul 31.

34.

The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.

Chui MH, Ryan P, Radigan J, Ferguson SE, Pollett A, Aronson M, Semotiuk K, Holter S, Sy K, Kwon JS, Soma A, Singh N, Gallinger S, Shaw P, Arseneau J, Foulkes WD, Gilks CB, Clarke BA.

Am J Surg Pathol. 2014 Sep;38(9):1173-81. doi: 10.1097/PAS.0000000000000298.

PMID:
25025451
35.

Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.

Simpson AN, Feigenberg T, Clarke BA, Gien LT, Ismiil N, Laframboise S, Massey C, Ferguson SE.

Gynecol Oncol. 2014 May;133(2):229-33. doi: 10.1016/j.ygyno.2014.02.020. Epub 2014 Feb 19.

PMID:
24561246
36.

The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.

Reade CJ, McVey RM, Tone AA, Finlayson SJ, McAlpine JN, Fung-Kee-Fung M, Ferguson SE.

J Obstet Gynaecol Can. 2014 Feb;36(2):133-140. doi: 10.1016/S1701-2163(15)30659-9. Review.

PMID:
24518912
37.

Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing.

Downes MR, Allo G, McCluggage WG, Sy K, Ferguson SE, Aronson M, Pollett A, Gallinger S, Bilbily E, Shaw P, Clarke BA.

Histopathology. 2014 Aug;65(2):228-39. doi: 10.1111/his.12386. Epub 2014 Apr 16. Review.

PMID:
24495259
38.

Risk-reducing salpingectomy in Canada: a survey of obstetrician-gynaecologists.

Reade CJ, Finlayson S, McAlpine J, Tone AA, Fung-Kee-Fung M, Ferguson SE.

J Obstet Gynaecol Can. 2013 Jul;35(7):627-634. doi: 10.1016/S1701-2163(15)30894-X.

PMID:
23876640
39.

Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents.

Omondi NA, Ferguson SE, Majhail NS, Denzen EM, Buchanan GR, Haight AE, Labotka RJ, Rizzo JD, Murphy EA.

J Pediatr Hematol Oncol. 2013 May;35(4):289-98. doi: 10.1097/MPH.0b013e31828d5e6a.

40.

Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.

Barlin JN, Dao F, Bou Zgheib N, Ferguson SE, Sabbatini PJ, Hensley ML, Bell-McGuinn KM, Konner J, Tew WP, Aghajanian C, Chi DS.

Gynecol Oncol. 2012 Jun;125(3):621-4. doi: 10.1016/j.ygyno.2012.03.027. Epub 2012 Mar 21.

PMID:
22446622
41.

Psychosexual distress in women with gynecologic cancer: a feasibility study of an online support group.

Classen CC, Chivers ML, Urowitz S, Barbera L, Wiljer D, O'Rinn S, Ferguson SE.

Psychooncology. 2013 Apr;22(4):930-5. doi: 10.1002/pon.3058. Epub 2012 Feb 28.

PMID:
22374732
42.

Confirmatory factor analysis of the Sexual Adjustment and Body Image Scale in women with gynecologic cancer.

Ferguson SE, Urowitz S, Massey C, Wegener M, Quartey N, Wiljer D, Classen CC.

Cancer. 2012 Jun 15;118(12):3095-104. doi: 10.1002/cncr.26632. Epub 2011 Dec 2.

43.

Informational needs of gynecologic cancer survivors.

Papadakos J, Bussière-Côté S, Abdelmutti N, Catton P, Friedman AJ, Massey C, Urowitz S, Ferguson SE.

Gynecol Oncol. 2012 Mar;124(3):452-7. doi: 10.1016/j.ygyno.2011.10.030. Epub 2011 Oct 30.

PMID:
22047740
44.

Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.

Ryan P, Mulligan AM, Aronson M, Ferguson SE, Bapat B, Semotiuk K, Holter S, Kwon J, Kalloger SE, Gilks CB, Gallinger S, Pollett A, Clarke BA.

Cancer. 2012 Feb 1;118(3):681-8. doi: 10.1002/cncr.26323. Epub 2011 Jun 30.

45.

A qualitative study of an internet-based support group for women with sexual distress due to gynecologic cancer.

Wiljer D, Urowitz S, Barbera L, Chivers ML, Quartey NK, Ferguson SE, To M, Classen CC.

J Cancer Educ. 2011 Sep;26(3):451-8. doi: 10.1007/s13187-011-0215-1.

PMID:
21594587
46.

Complementary and alternative medicine use among women receiving chemotherapy for ovarian cancer in 2 patient populations.

Helpman L, Ferguson SE, Mackean M, Rana A, Le L, Atkinson MA, Rogerson A, Mackay H.

Int J Gynecol Cancer. 2011 Apr;21(3):587-93. doi: 10.1097/IGC.0b013e31820fa24a.

PMID:
21436708
47.

Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer.

Kehoe SM, Zivanovic O, Ferguson SE, Barakat RR, Soslow RA.

Gynecol Oncol. 2010 May;117(2):229-33. doi: 10.1016/j.ygyno.2010.01.047. Epub 2010 Mar 2.

PMID:
20199802
48.

A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery.

Ferguson SE, Malhotra T, Seshan VE, Levine DA, Sonoda Y, Chi DS, Barakat RR, Abu-Rustum NR.

Gynecol Oncol. 2009 Jul;114(1):111-6. doi: 10.1016/j.ygyno.2009.03.014. Epub 2009 Apr 23.

PMID:
19395071
49.

Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.

Black D, Levine DA, Nicoll L, Chou JF, Iasonos A, Brown CL, Sonoda Y, Chi DS, Leitao MM, Abu-Rustum NR, Ferguson SE, Barakat RR.

Gynecol Oncol. 2008 Apr;109(1):39-42. doi: 10.1016/j.ygyno.2007.12.004. Epub 2008 Jan 29.

PMID:
18234300
50.

Prognostic features of surgical stage I uterine carcinosarcoma.

Ferguson SE, Tornos C, Hummer A, Barakat RR, Soslow RA.

Am J Surg Pathol. 2007 Nov;31(11):1653-61.

PMID:
18059221

Supplemental Content

Loading ...
Support Center